Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer GrowthHallie M. Hintz, Aaron M. LeBeau|Cancer Immunology Research|2021Cited by 21